ADNTRO GENETICS

Adntro Genetics is a cutting-edge startup focused on genetic progress, with a vision to make understanding one's unique genetic code accessible to everyone. Founded in 2020 and based in Spain, the company operates in the Biopharma and Health Care industries, with a commitment to navigating the expanding landscape of genetic information and scientific advancements. The company's slogan, "Love your DNA 🧬," encapsulates its mission to inspire new ideas and scientific approaches through the exploration of genetic data. The completion of the human genetic code in 2003 has sparked an exponential growth in studies and information on genetic markers, driving a deeper understanding of genotype-phenotype relationships. Adntro Genetics aims to aid individuals in keeping up with these developments and making informed decisions about their genetic makeup. Notably, the startup secured a Seed Round investment on 01 May 2022, with Addendum Capital as the investor. This investment underscores the confidence of Addendum Capital in Adntro Genetics’ potential to make a lasting impact in the genetic research and healthcare sectors. As the company continues to progress, its innovative approach and strategic positioning make it a compelling prospect for investors seeking opportunities in the rapidly evolving field of genetic science.